Adyary Fallarero

Dr. Adyary Fallarero


Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
NSNiklas Sandler
Niklas Sandler
ISIda Salmela
Ida Salmela
AFAdyary Fallarero
Adyary Fallarero
ARAri Rosling
Ari Rosling
MKMohammad Khajeheian
Mohammad Khajeheian
PVPia Vuorela
Pia Vuorela

1 December 2003 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
AVAlexis Vidal
Alexis Vidal
AFAdyary Fallarero
Adyary Fallarero
BPBlanca R Peña
Blanca R Peña
MMMaria E Medina
Maria E Medina
BGBienvenido Gra
Bienvenido Gra
PVPia M Vuorela
Pia M Vuorela

27 June 2012 in The Journal of Antibiotics
Verified
Journal Article
Closed access
MSMalena Skogman
Malena Skogman
PVPia Maarit Vuorela
Pia Maarit Vuorela
AFAdyary Fallarero
Adyary Fallarero

22 November 2006 in Plant Foods for Human Nutrition
Verified
Journal Article
Closed access
PDF file
JFJoaquim Mauricio Duarte-Almeida lab. Farmacognosia
Joaquim Mauricio Duarte-Almeida lab. Farmacognosia
ANAlexis Vidal Novoa
Alexis Vidal Novoa
AFAdyary Fallarero
Adyary Fallarero
FLFranco M. Lajolo
Franco M. Lajolo
MGMaria Inés Genovese
Maria Inés Genovese

Verified
Journal Article
Open access
PDF file
SMSuvi Manner
Suvi Manner
MSMalena Skogman
Malena Skogman
DGDarla Goeres
Darla Goeres
PVPia Vuorela
Pia Vuorela
AFAdyary Fallarero
Adyary Fallarero
When single-cell (or suspended) bacteria switch into the biofilm lifestyle, they become less susceptible to antimicrobials, imposing the need for anti-biofilms research. Flavonoids are among the most extensively studied natural compounds with an unprecedented amount of bioactivity claims. Most studies focus on the antibacterial effects against suspended cells; fewer reports have researched their anti-biofilm properties. Here, a high throughput phenotypic platform was utilized to screen for the inhibitory activity of 500 flavonoids, including natural and synthetic derivatives, against Staphylococcus aureus biofilms. Since discrepancies among results from earlier antibacterial studies on flavonoids had been noted, the current study aimed to minimize sources of variations. After the first screen, flavonoids were classified as inactive (443), moderately active (47) or highly active (10). Further, exclusion criteria combining bioactivity and selectivity identified two synthetic flavans as the most promising. The body of data reported here serves three main purposes. First, it offers an improved methodological workflow for anti-biofilm screens of chemical libraries taking into account the (many times ignored) connections between anti-biofilm and antibacterial properties. This is particularly relevant for the study of flavonoids and other natural products. Second, it provides a large and freely available anti-biofilm bioactivity dataset that expands the knowledge on flavonoids and paves the way for future structure-activity relationship studies and structural optimizations. Finally, it identifies two new flavans that can successfully act on biofilms, as well as on suspended bacteria and represent more feasible antibacterial candidates.

1 July 2009 in Journal of Microbiological Methods
Verified
Journal Article
Closed access
MSMalena E. Sandberg
Malena E. Sandberg
DSDenise Schellmann
Denise Schellmann
GBGerda Brunhofer
Gerda Brunhofer
TEThomas Erker
Thomas Erker
IBIgor Busygin
Igor Busygin
AFAdyary Fallarero
Adyary Fallarero